Beginning Cash: The amount of cash reported by the company on its previous statement.
Nymox Pharmaceutical Corporation (NYMXF) had Beginning Cash of $0.07M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-0.72M |
|
-- |
|
-- |
|
$0.65M |
|
$-0.65M |
|
$-0.06M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.65M |
|
$-0.65M |
|
93.54M |
|
93.54M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.62M |
|
$0.00M |
|
$0.00M |
|
$0.62M |
|
$6.92M |
|
-- |
|
-- |
|
$6.92M |
|
$-6.30M |
|
$-6.30M |
|
$-6.30M |
|
93.54M |
|
| Cash Flow Statement Financials | |
$-1.88M |
|
-- |
|
$1.85M |
|
|
Beginning Cash |
$0.07M |
$0.04M |
|
$-0.03M |
|
$0.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
11.37% |
|
11.37% |
|
-114.74% |
|
11.37% |
|
$-0.07 |
|
$-0.02 |
|
$-0.02 |
|